Daniel Arnold spent the last two months photographing parks in all five boroughs. The experience showed him “a very different pulse of the city.”
NYS Entity Status
NYS Filing Date
OCTOBER 08, 2013
NYS DOS ID#
NYS Entity Type
DOMESTIC BUSINESS CORPORATION
2013 - NEW BUSINESS RESOURCES GROUP INC
Around the Web
- The Look: New York City Parks in the Summer: Romance, Games and a Performance for a Dying Tree
By DANIEL ARNOLD, JOANNA NIKAS and EVE LYONS - Saturday Sep 2, 2017
- Bill Ackman is playing Jekyll-and-Hyde with ADP
By Carleton English - Wednesday Sep 13, 2017
It looks like Bill Ackman is trying Jekyll-and-Hyde tactics to shake up Automatic Data Processing’s board. The activist investor’s hedge fund Pershing Square said Wednesday that it wants to replace three of ADP’s board members as he pressed the payroll processor to cut costs and update its technology. That’s an abrupt turn from last week,...
- Anthem Confirms Swedish to Step Down as CEO
Monday Nov 6, 2017
Anthem Inc. has named the former chief executive of UnitedHealth Group Inc.’s insurance business, Gail Boudreaux, its new president and chief executive officer.
- For 18 Hours, Cabbie Sat Dead in Front Seat
By KIM BARKER - Monday Aug 14, 2017
A driver parked his taxi to take a break in SoHo. He died behind the wheel. Then, for nearly a day, New Yorkers went about their lives — just feet from his body.
- Food & Wine Magazine Will Leave New York for Alabama
By STEPHANIE STROM - Friday Jun 23, 2017
The move reflects a changing business in which traditional food magazines, and a Manhattan address, are less important.
- Cancer drug research moving fast in immunotherapy field
By Michelle Fay Cortez - Tuesday Sep 5, 2017
The last few weeks have been historic in the fight against cancer. Novartis got approval for the first treatment in a revolutionary new class of drugs, shortly after Gilead Sciences Inc. spent $11.9 billion on a biotech company working in the field. Neither can rest on its laurels. Research in the field is moving so fast that today’s breakthroughs can easily become tomorrow’s has-beens. “I can’t think of any other therapies in oncology that have seen such rapid development,” said Rachel Webster, senior director of oncology at Decision Resources Group, a health care research and consulting firm in London.